African and asian zika virus isolates display phenotypic differences both in vitro and in vivo

American Journal of Tropical Medicine and Hygiene

Volumn 98, Issue 2, 2018, Pages 432-444

  Smith, Darci R ^a   Sprague, Thomas R ^a   Hollidge, Bradley S ^a   Valdez, Stephanie M ^a   Padilla, Susana L ^a   Bellanca, Stephanie A ^a   Golden, Joseph W ^a   Coyne, Susan R ^a   Kulesh, David A ^a   Miller, Lynn Jean ^a   Haddow, Andrew D ^a   Koehler, Jeff W ^a   Gromowski, Gregory D ^b   Jarman, Richard G ^b   Alera, Maria Theresa P ^c   Yoon, In Kyu ^d   Buathong, Rome ^e   Lowen, Robert G ^a   Kane, Christopher D ^a   Minogue, Timothy D ^a   Bavari, Sina ^a   Tesh, Robert B ^f   Weaver, Scott C ^f   Linthicum, Kenneth J ^g   Pitt, Margaret L ^a   Nasar, Farooq ^a,f   more..

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d International Vaccine Institute   (South Korea)

^e MINISTRY OF PUBLIC HEALTH   (Thailand)

^f University of Texas Medical Branch School of Medicine   (United States)

^g CENTER FOR MEDICAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEDES AEGYPTI; AFRICA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASIA; CONTROLLED STUDY; FEMALE; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LD50; MORTALITY RATE; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; VERO CELL LINE; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS VIRULENCE; ZIKA FEVER; ZIKA VIRUS; AEDES; ANIMAL; BIOLOGICAL VARIATION; C57BL MOUSE; DISEASE MODEL; GENETICS; ISOLATION AND PURIFICATION; MOSQUITO VECTOR; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY; WESTERN HEMISPHERE;

AEDES; AFRICA; AMERICAS; ANIMALS; ASIA; BIOLOGICAL VARIATION, POPULATION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MOSQUITO VECTORS; REAL-TIME POLYMERASE CHAIN REACTION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85041551570     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.17-0685     Document Type: Article

References (74)

1. Fields BN, Knipe DM, Howley PM, 2013. Flaviviridae in Fields Virology. Philadelphia:Wolters KluwerHealth/LippincottWilliams & Wilkins.
2. Sirohi D, Chen Z, Sun L, Klose T, Pierson TC, Rossmann MG, Kuhn RJ, 2016. The 3.8 Aresolution cryo-EM structure of Zika virus. Science 352: 467-470.
3. DickGW,KitchenSF,HaddowAJ, 1952.Zika virus. I. Isolations and serological specificity. Trans R Soc TropMed Hyg 46: 509-520.
4. Boorman JP, Porterfield JS, 1956.Asimple technique for infection of mosquitoes with viruses; transmission of Zika virus. Trans R Soc Trop Med Hyg 50: 238-242.
5. Dick GW, 1952. Zika virus. II. Pathogenicity and physical properties. Trans R Soc Trop Med Hyg 46: 521-534.
6. Moore DL, Causey OR, Carey DE, Reddy S, Cooke AR, Akinkugbe FM, David-West TS, Kemp GE, 1975. Arthropod-borne viral infections of man in Nigeria, 1964-1970. Ann Trop Med Parasitol 69: 49-64.
7. Fagbami A, 1977. Epidemiological investigations on arbovirus infections at Igbo-Ora, Nigeria. Trop Geogr Med 29: 187-191.
8. Fagbami AH, 1979. Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State. J Hyg (Lond) 83: 213-219.
9. Robin Y, Mouchet J, 1975. Serological and entomological study on yellow fever in Sierra Leone [in French]. Bull Soc Pathol Exot Filiales 68: 249-258.
10. Olson JG, Ksiazek TG, Suhandiman , Triwibowo , 1981. Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg 75: 389-393.
11. Jan C, Languillat G, Renaudet J, Robin Y, 1978. A serological survey of arboviruses in Gabon [in French]. Bull Soc Pathol Exot Filiales 71: 140-146.
12. Saluzzo JF, Gonzalez JP, Herve JP, Georges AJ, 1981. Serological survey for the prevalence of certain arboviruses in the human population of the south-east area of Central African Republic (author's transl) [in French]. Bull Soc Pathol Exot Filiales 74: 490-499.
13. Saluzzo JF, Ivanoff B, LanguillatG, Georges AJ, 1982. Serological survey for arbovirus antibodies in the human and simian populations of the south-east of Gabon (author's transl) [in French]. Bull Soc Pathol Exot Filiales 75: 262-266.
14. Marchette NJ, Garcia R, Rudnick A, 1969. Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am J Trop Med Hyg 18: 411-415.
15. MonlunEet al., 1993. Surveillance of the circulation of arbovirus of medical interest in the region of eastern Senegal [in French]. Bull Soc Pathol Exot Filiales 86: 21-28.
16. Akoua-Koffi C, Diarrassouba S, Benie VB, Ngbichi JM, Bozoua T, Bosson A, Akran V, Carnevale P, Ehouman A, 2001. Investigation surrounding a fatal case of yellow fever in Cote d'Ivoire in 1999 [in French]. Bull Soc Pathol Exot Filiales 94: 227-230.
17. Olson JG, Ksiazek TG, Gubler DJ, Lubis SI, Simanjuntak G, Lee VH, Nalim S, Juslis K, See R, 1983. A survey for arboviral antibodies in sera of humans and animals in Lombok, Republic of Indonesia. Ann Trop Med Parasitol 77: 131-137.
18. McCrae AW, Kirya BG, 1982. Yellow fever and Zika virus epizootics and enzootics in Uganda. Trans R Soc Trop Med Hyg 76: 552-562.
19. Darwish MA, Hoogstraal H, Roberts TJ, Ahmed IP, Omar F, 1983. A sero-epidemiological survey for certain arboviruses (Togaviridae) in Pakistan. Trans R Soc Trop Med Hyg 77: 442-445.
20. Dowd KA et al., 2016. Broadly neutralizing activity of Zika virusimmune sera identifies a single viral serotype. Cell Reports 16: 1485-1491.
21. Haddow AD, Schuh AJ, Yasuda CY, Kasper MR, Heang V, Huy R, Guzman H, Tesh RB, Weaver SC, 2012. Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl Trop Dis 6: e1477.
22. Duffy MR et al., 2009. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 360: 2536-2543.
23. Grard G, Caron M, Mombo IM, Nkoghe D, Mboui Ondo S, Jiolle D, Fontenille D, Paupy C, Leroy EM, 2014. Zika virus in Gabon (Central Africa)-2007: a new threat from Aedes albopictus? PLoS Negl Trop Dis 8: e2681.
24. Musso D, Nilles EJ, Cao-Lormeau VM, 2014. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect 20: O595-O596.
25. Campos GS, Bandeira AC, Sardi SI, 2015. Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis 21: 1885-1886.
26. Zanluca C, Melo VC, Mosimann AL, Santos GI, Santos CN, Luz K, 2015. First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz 110: 569-572.
27. Musso D, 2015. Zika virus transmission from French Polynesia to Brazil. Emerg Infect Dis 21: 1887.
28. Musso D, Gubler DJ, 2016. Zika virus. Clin Microbiol Rev 29: 487-524.
29. Petersen LR, Jamieson DJ, Powers AM, Honein MA, 2016. Zika virus. N Engl J Med 374: 1552-1563.
30. Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S, Valour F, Baudouin L, Mallet H, Musso D, Ghawche F, 2014. Zika virus infection complicated by Guillain-Barre syndrome-case report, French Polynesia, December 2013. Euro Surveill 19: 20720.
31. Krauer F, Riesen M, Reveiz L, Oladapo OT, Martinez-Vega R, Porgo TV, Haefliger A, Broutet NJ, Low N; WHO Zika Causality Working Group, 2017. Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barre syndrome: systematic review. PLoS Med 14: e1002203.
32. Foy BD, Kobylinski KC, Chilson Foy JL, Blitvich BJ, Travassos da Rosa A, Haddow AD, Lanciotti RS, Tesh RB, 2011. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 17: 880-882.
33. D'Ortenzio E, Matheron S, Yazdanpanah Y, de Lamballerie X, Hubert B, Piorkowski G, Maquart M, Descamps D, Damond F, Leparc-Goffart I, 2016. Evidence of sexual transmission of Zika virus. N Engl J Med 374: 2195-2198.
34. Haddow AD et al., 2017. High infection rates for adult macaques after intravaginal or intrarectal inoculation with Zika virus. Emerg Infect Dis 23: 1274-1281.
35. Edgar RC, 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32: 1792-1797.
36. Gouy M, Guindon S, Gascuel O, 2010. SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol 27: 221-224.
37. Felsenstein J, 1989. PHYLIP: phylogeny inference package (Version 3.2). Cladistics 5: 164-166.
38. Posada D, Crandall KA, 1998. MODELTEST: testing the model of DNA substitution. Bioinformatics 14: 817-818.
39. Pilitt DR, Jones JC, 1972. A qualitative method for estimating the degree of engorgement of Aedes aegypti adults. JMedEntomol 9: 334-337.
40. Ellison DW et al., 2016. Complete genome sequences of Zika virus strains isolated from the blood of patients in Thailand in 2014 and the Philippines in 2012. Genome Announc 4: pii: e00359-16.
41. Widman DG et al., 2017. A reverse genetics platform that spans the Zika virus family tree. MBio 8: pii: e02014-16.
42. Ladner JT et al., 2016. Complete genome sequences of five Zika virus isolates. Genome Announc 4: pii: e00377-16.
43. Smith DR et al., 2017. Neuropathogenesis of Zika virus in a highly susceptible immunocompetent mouse model after antibody blockade of type I interferon. PLoS Negl Trop Dis 11: e0005296.
44. Lazear HM, Govero J, Smith AM, Platt DJ, Fernandez E,Miner JJ, Diamond MS, 2016.A mouse model of Zika virus pathogenesis. Cell Host Microbe 19: 720-730.
45. Weger-Lucarelli J et al., 2016. Vector competence of American mosquitoes for three strains of Zika virus. PLoS Negl Trop Dis 10: e0005101.
46. Simonin Y et al., 2016. Zika virus strains potentially display different infectious profiles in human neural cells. EBioMedicine 12: 161-169.
47. Rossi SL, Tesh RB, Azar SR, Muruato AE, Hanley KA, Auguste AJ, Langsjoen RM, Paessler S, Vasilakis N, Weaver SC, 2016. Characterization of a novel murine model to study Zika virus. Am J Trop Med Hyg 94: 1362-1369.
48. Chan JF et al., 2016. Differential cell line susceptibility to the emerging Zika virus: implications for disease pathogenesis, non-vector-borne human transmission and animal reservoirs. Emerg Microbes Infect 5: e93.
49. Dowall SD, Graham VA, Rayner E, Atkinson B, Hall G, Watson RJ, Bosworth A, Bonney LC, Kitchen S, Hewson R, 2016. A susceptible mouse model for Zika virus infection. PLoS Negl Trop Dis 10: e0004658.
50. Setoh YX, Prow NA, Peng N, Hugo LE, Devine G, Hazlewood JE, Suhrbier A, Khromykh AA, 2017. De novo generation and characterization of New Zika virus isolate using sequence data from a microcephaly case. mSphere 2: pii: e00190-17.
51. Duggal NK, Ritter JM, McDonald EM,RomoH, Guirakhoo F, Davis BS, Chang GJ, Brault AC, 2017. Differential neurovirulence of African and Asian genotype Zika virus isolates in outbred immunocompetent mice. Am J Trop Med Hyg 97: 1410-1417.
52. Muylaert IR, Galler R, Rice CM, 1997. Genetic analysis of the yellow fever virus NS1 protein: identification of a temperaturesensitive mutation which blocks RNA accumulation. J Virol 71: 291-298.
53. Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ, 2001. Molecular basis for attenuation of neurovirulence of a yellow fever virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol 75: 934-942.
54. Arroyo J, Miller C, Catalan J, Myers GA, Ratterree MS, Trent DW, Monath TP, 2004. ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J Virol 78: 12497-12507.
55. Mandl CW, Allison SL, Holzmann H, Meixner T, Heinz FX, 2000. Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol 74: 9601-9609.
56. Monath TP, Arroyo J, Levenbook I, Zhang ZX, Catalan J, Draper K, Guirakhoo F, 2002. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J Virol 76: 1932-1943.
57. Zhao Z, Date T, Li Y, Kato T, Miyamoto M, Yasui K, Wakita T, 2005. Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectiouscDNA clone. J Gen Virol 86: 2209-2220.
58. Hurrelbrink RJ, McMinn PC, 2001. Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein. J Virol 75: 7692-7702.
59. Liu WJ, Chen HB, Khromykh AA, 2003. Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication. J Virol 77: 7804-7813.
60. de Wispelaere M, Yang PL, 2012. Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assembly. J Virol 86: 7072-7083.
61. Bray M, Men R, Tokimatsu I, Lai CJ, 1998. Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence. J Virol 72: 1647-1651.
62. Gualano RC, Pryor MJ, Cauchi MR, Wright PJ, Davidson AD, 1998. Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomiclength cDNA. J Gen Virol 79: 437-446.
63. Prestwood TR, Prigozhin DM, Sharar KL, Zellweger RM, Shresta S, 2008. A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads. J Virol 82: 8411-8421.
64. Tajima S, NeromeR, Nukui Y, Kato F, Takasaki T, Kurane I, 2010.A single mutation in the Japanese encephalitis virus E protein (S123R) increases its growth rate in mouse neuroblastoma cells and its pathogenicity in mice. Virology 396: 298-304.
65. Rumyantsev AA, Murphy BR, Pletnev AG, 2006. A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice. J Virol 80: 1427-1439.
66. Jerzak GV, Brown I, Shi PY, Kramer LD, Ebel GD, 2008. Genetic diversity and purifying selection in West Nile virus populations are maintained during host switching. Virology 374: 256-260.
67. Grubaugh ND et al., 2015. Experimental evolution of an RNA virus in wild birds: evidence for host-dependent impacts on population structure and competitive fitness. PLoS Pathog 11: e1004874.
68. Deardorff ER, Fitzpatrick KA, Jerzak GV, Shi PY, Kramer LD, Ebel GD, 2011. West Nile virus experimental evolution in vivo and the trade-off hypothesis. PLoS Pathog 7: e1002335.
69. Vasilakis N, Deardorff ER, Kenney JL, Rossi SL, Hanley KA, Weaver SC, 2009. Mosquitoes put the brake on arbovirus evolution: experimental evolution reveals slower mutation accumulation in mosquito than vertebrate cells. PLoS Pathog 5: e1000467.
70. GooL, VanBlarganLA,DowdKA,DiamondMS, PiersonTC, 2017. A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis. PLoS Pathog 13: e1006178.
71. Erb SM, Butrapet S, Moss KJ, Luy BE, Childers T, Calvert AE, Silengo SJ, Roehrig JT, Huang CY, Blair CD, 2010. Domain-III FGloop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes. Virology 406: 328-335.
72. Beasley DW, Whiteman MC, Zhang S, Huang CY, Schneider BS, Smith DR, Gromowski GD, Higgs S, Kinney RM, Barrett AD, 2005. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J Virol 79: 8339-8347.
73. Gromowski GD, Firestone CY, Whitehead SS, 2015. Genetic determinants of Japanese encephalitis virus vaccine strain SA14-14-2 that govern attenuation of virulence in mice. J Virol 89: 6328-6337.
74. Liu Y et al., 2017. Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes. Nature 545: 482-486.